Početna › Wilmsov tumor › Texas
Kliničke studije za Wilmsov tumor u državi Texas
6 studija za Wilmsov tumor traži sudionike na lokacijama u državi Texas.
Gradovi u državi Texas
Službeni tekst studije (engleski)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
U tijeku regrutacijaFaza 2
Od 12 do 39 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT04616560A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- Dell Children's Medical Center of Central Texas, Austin
- Driscoll Children's Hospital, Corpus Christi
- Medical City Dallas Hospital, Dallas
- i još 10
U tijeku regrutacijaFaza 2
Do 30 godina · Oba spola · Ažurirano 25. kol 2026. · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
U tijeku regrutacijaFaza 1/2
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Texas Children's Hospital, Houston
U tijeku regrutacijaFaza 1
Od 1 do 21 godina · Oba spola · Ažurirano 6. kol 2026. · NCT04715191A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Cook Children's Health Care System (Data Collection Only), Fort Worth
U tijeku regrutacijaFaza 2
12 Months · Oba spola · Ažurirano 6. svi 2026. · NCT05985161Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
- Houston Methodist Hospital, Houston
U tijeku regrutacijaFaza 1
Do 21 godina · Oba spola · Ažurirano 3. stu 2025. · NCT06198296Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.